Correction: Heart rate variability provides prognostic value in multiple system atrophy

Paulo Bastos, Marc Kermorgant, Margherita Fabbri, Frederic Roche, Vincent Pichot, Fabienne Ory-Magne, Clémence Leung, Olivier Rascol, Wassilios G. Meissner, Alexandra Foubert-Samier, David Bendetowicz, Cécile Proust Lima, Anne Pavy-le-Traon
Clinical Autonomic Research. 2026-04-25; :
DOI: 10.1007/s10286-026-01214-3

1. Clin Auton Res. 2026 Apr 25. doi: 10.1007/s10286-026-01214-3. Online ahead of
print.

Correction: Heart rate variability provides prognostic value in multiple system
atrophy.

Bastos P(1)(2)(3), Kermorgant M(4)(5)(6), Fabbri M(7)(8)(4)(5)(6), Roche F(9),
Pichot V(9), Ory-Magne F(7)(4)(10), Leung C(7)(4)(10), Rascol O(7)(8)(4)(5), G
Meissner W(11)(12)(13), Foubert-Samier A(11)(12), Bendetowicz D(11)(12), Proust
Lima C(14), Pavy-le-Traon A(4)(5)(6).

Author information:
(1)Department of Clinical Pharmacology and Neurosciences, University of Toulouse
3, Hôpital Pierre Paul Riquet, Toulouse University Hospital, Place du Dr Baylac,
31059, Toulouse, France. .
(2)French Clinical Research Network (F-CRIN) for Parkinson’s Disease and
Movement Disorders (NS-Park-F-CRIN), Toulouse, France.
.
(3)Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.
.
(4)Clinical Investigation Center CIC 1436, CHU de Toulouse, Toulouse, France.
(5)French MSA Reference Center, Neurology Department, Toulouse University
Hospital, Toulouse, France.
(6)ToNIC – Toulouse Neuro Imaging Center – INSERM – UMR 1214, Toulouse, France.
(7)Department of Clinical Pharmacology and Neurosciences, University of Toulouse
3, Hôpital Pierre Paul Riquet, Toulouse University Hospital, Place du Dr Baylac,
31059, Toulouse, France.
(8)French Clinical Research Network (F-CRIN) for Parkinson’s Disease and
Movement Disorders (NS-Park-F-CRIN), Toulouse, France.
(9)Department of Clinical and Exercise Physiology Saint-Etienne University
Hospital, Jean Monnet University, Saint-Etienne, France.
(10)Centre de Référence Constitutif des Syndromes Paranéoplasiques et
Encéphalites Auto-Immunes, CHU Toulouse, Toulouse, France.
(11)Service de Neurologie des Maladies Neurodégénératives, IMNc, CRMR AMS, CHU
Bordeaux, Bordeaux, France.
(12)University of Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, France.
(13)Department of Medicine, University of Otago, Christchurch, and New Zealand
Brain Research Institute, Christchurch, New Zealand.
(14)INSERM, UMR1219, Bordeaux Population Health Research Center, University of
Bordeaux, ISPED, Bordeaux, France.